p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

Wales, Michele Makos, Biel, Margaret A., Deiry, Wafik El, Nelkin, Barry D., Issa, Jean-Pierre, Cavenee, Webster K., Kuerbitz, Steven J., Baylin, Stephen B.·1995·Nature Medicine
DOI 10.1038/nm0695-570

Cited by (420)

Items 201–300 of 420

  1. Characterization of HRG22, a Human Homologue of the Putative Tumor Suppressor Gene HIC1
    Sophie Deltour, Sébastien Pinte, Cateline Guérardel, Dominique Leprince · 2001 · Biochemical and Biophysical Research Communications
  2. Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer
    J R Dunn, Julie Garde, Kevin Dolan, John R. Gosney, Robert Sutton, Stephen J. Meltzer, John K. Field · 1999 · Oncogene
  3. Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers.
    Hiroyuki Konishi, Taku Nakagawa, Tomoko Harano, Kotaro Mizuno, Hiroko Saito, Akira Masuda, Hikaru Matsuda, Hirotaka Osada, Takashi Takahashi · 2002 · PubMed
  4. Role of epigenetic changes in hematological malignancies
    Ulrich Lehmann, Kai Brakensiek, Hans Heinrich Kreipe · 2004 · Annals of Hematology
  5. The tumor suppressor HIC1 (hypermethylated in cancer 1) is O ‐GlcNAc glycosylated
    Tony Lefebvre, Sébastien Pinte, Cateline Guérardel, Sophie Deltour, Nathalie Martin, Marie‐Christine Slomianny, Jean‐Claude Michalski, Dominique Leprince · 2004 · European Journal of Biochemistry
  6. Mnt-Deficient Mammary Glands Exhibit Impaired Involution and Tumors with Characteristics of Myc Overexpression
    Kazuhito Toyo‐oka, Timothy J. Bowen, Shinji Hirotsune, Zirong Li, Sonia Jain, Sara Ota, Laure Escoubet‐Lozach, Ivan García-Bassets, Jean Lozach, Michael G. Rosenfeld et al. · 2006 · Cancer Research
  7. Molecular and Cellular Changes During Cancer Progression Resulting From Genetic and Epigenetic Alterations
    Kevin Pruitt · 2016 · Progress in molecular biology and translational science
  8. Loss of Hypermethylated in Cancer 1 (HIC1) in Breast Cancer Cells Contributes to Stress-induced Migration and Invasion through β-2 Adrenergic Receptor (ADRB2) Misregulation
    Gaylor Boulay, Nicolas Malaquin, Ingrid Loison, Bénédicte Foveau, Capucine Van Rechem, Brian R. Rood, Albin Pourtier, Dominique Leprince · 2011 · Journal of Biological Chemistry
  9. HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage–Associated Tumorigenesis
    Lucie Janečková, Vendula Pospíchalová, Bohumil Fafílek, Martina Vojtěchová, Jolana Turečková, Jan Dobeš, Marion Dubuissez, Dominique Leprince, Nikol Dibus, Monika Horázná et al. · 2015 · Molecular Cancer Research
  10. Molecular mechanisms underlying eicosapentaenoic acid inhibition of HDAC1 and DNMT expression and activity in carcinoma cells
    Veronica Ceccarelli, Simona Ronchetti, Maria Cristina Marchetti, Mario Calvitti, Carlo Riccardi, Francesco Grignani, Alba Vecchini · 2020 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  11. Signification of Hypermethylated in Cancer 1 (HIC1) as Tumor Suppressor Gene in Tumor Progression
    Jianghua Zheng, Dan Xiong, Xueqing Sun, Jinglong Wang, Mingang Hao, Tao Ding, Gang Xiao, Xiumin Wang, Yan Mao, Yuejie Fu et al. · 2012 · Cancer Microenvironment
  12. Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas
    Abdullah Alholle, Anna Teresa Brini, J Bauer, Seley Gharanei, Stefania Niada, A Slater, Dean Gentle, Eamonn Richard Maher, Lee Marcus Jeys, Robert John Grimer et al. · 2015 · Epigenetics
  13. Extensive Intra-tumor Heterogeneity in Primary Human Glial Tumors as a Result of Locus Non-specific Genomic Alterations
    Anjan Misra, Parthaprasad Chattopadhyay, Amit Kr. Dinda, Chitra Sarkar, Ashok K. Mahapatra, Seyed E. Hasnain, Subrata Sinha · 2000 · Journal of Neuro-Oncology
  14. The Receptor Tyrosine Kinase EphA2 Is a Direct Target Gene of Hypermethylated in Cancer 1 (HIC1)
    Bénédicte Foveau, Gaylor Boulay, Sébastien Pinte, Capucine Van Rechem, Brian R. Rood, Dominique Leprince · 2011 · Journal of Biological Chemistry
  15. Cervical cancer pathogenesis is associated with one-carbon metabolism
    Sujata Pathak, Neerja Bhatla, Neeta Singh · 2012 · Molecular and Cellular Biochemistry
  16. HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation
    Christian Britschgi, Mathias Jenal, Mattia Rizzi, Beatrice U. Mueller, Bruce Edward Torbett, Anne‐Catherine Andres, Andreas Tobler, Martin F. Fey, Mario P. Tschan · 2008 · British Journal of Haematology
  17. Role of the Cytosine Dna-Methyltransferase and p16 nk4a Genes in the Development of Mouse Lung Tumors
    Steven A. Belinsky · 1998 · Experimental Lung Research
  18. DNA hypermethylation markers of poor outcome in laryngeal cancer
    Josena K. Stephen, Kang Mei Chen, Veena V. Shah, Shaleta Havard, Alissa Kapke, Mei Lü, Michael S. Benninger, Maria J. Worsham · 2010 · Clinical Epigenetics
  19. Cellular taxonomy of Hic1+ mesenchymal progenitor derivatives in the limb: from embryo to adult
    Martin Arostegui, R. Wilder Scott, Kerstin Böse, T. Michael Underhill · 2022 · Nature Communications
  20. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T‐prolymphocytic leukaemia and Sezary syndrome
    V Brito-Babapulle, Rifat Hamoudi, Estella Matutes, S. Watson, Pawel A Kaczmarek, H. Maljaie, Daniel Catovsky · 2000 · British Journal of Haematology
  21. Functional studies of the BTB domain in the Drosophila GAGA and Mod(mdg4) proteins
    Douglas B. Read · 2000 · Nucleic Acids Research
  22. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array
    Steffen Backert, Marcos Gelos, Ursula Kobalz, Marie‐Luise Hanski, Christian B�hm, Benno Mann, Nicole L�vin, Alexei N. Gratchev, Ulrich Mannsmann, Mary Pat Moyer et al. · 1999 · International Journal of Cancer
  23. Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma
    Wenyi Wu, Liting Zhang, Jianqing Lin, Hanwei Huang, Bai Shi, Xingong Lin, Zhongxin Huang, Chaoyang Wang, Qiu Jianlong, Xiaolong Wei · 2016 · Oncotarget
  24. HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast
    Paola Parrella, Marina Scintu, Maria Prencipe, Maria Luana Poeta, Antonietta Pia Gallo, Carla Rabitti, Monica Rinaldi, Stefania Tommasi, Angelo Paradiso, Francesco Schittulli et al. · 2004 · Cancer Letters
  25. Cellular reprogramming to reset epigenetic signatures
    Kyle J. Hewitt, Jonathan A. Garlick · 2012 · Molecular Aspects of Medicine
  26. Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses
    Yrjö Tapio Konttinen, Tian-Fang Li, Jami Mandelin, Mari Ainola, Jan Lassus, Ismo Virtanen, Seppo S. Santavirta, Markku Tammi, Raija Tammi · 2001 · The Journal of Pathology
  27. The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53
    Anette Szczepny, Kirstyn T. Carey, Lisa D. McKenzie, W. Samantha N. Jayasekara, Fernando Jaime Rossello, Álvaro González-Rajal, Andrew McCaw, Dean Popovski, Die Wang, Anthony John Sadler et al. · 2018 · Oncogene
  28. Heterogeneity of DNA Methylation Status Analyzed by Bisulfite-PCR-SSCP and Correlation with Clinico-Pathological Characteristics in Colorectal Cancer
    Masato Maekawa, Kokichi Sugano, Mineko Ushiama, Noriko Fukayama, Kiyoaki Nomoto, Hidefumi Kashiwabara, Shin Fujita, Tadao Kakizoe · 2001 · Clinical Chemistry and Laboratory Medicine (CCLM)
  29. Molecular Basis of Multistep Hepatocarcinogenesis: Genetic and Epigenetic Events
    Ai-Min Hui, M. Makuuchi · 1999 · Scandinavian Journal of Gastroenterology
  30. Opposite Roles of the JMJD1A Interaction Partners MDFI and MDFIC in Colorectal Cancer
    Yuan Sui, Xiaomeng Li, Sangphil Oh, Bin Zhang, Willard M. Freeman, Sook Shin, Ralf Janknecht · 2020 · Scientific Reports
  31. Characterization of ΔNp73 expression and regulation in gastric and esophageal tumors
    Anna E. Vilgelm, S-M Hong, Mary Kay Washington, Wei Ji, Heidi Chen, W El-Rifai, Alexander I. Zaika · 2010 · Oncogene
  32. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma
    M. Kuczyk · 2012 · International Journal of Oncology
  33. The Tumor Suppressor Gene Hypermethylated in Cancer 1 Is Transcriptionally Regulated by E2F1
    Mathias Jenal, Emmanuelle Trinh, Christian Britschgi, Adrian Britschgi, Vincent Roh, Stephan A. Vorburger, Andreas Tobler, Dominique Leprince, Martin F. Fey, Kristian Helin et al. · 2009 · Molecular Cancer Research
  34. HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1
    Valentin Le Douce, Faezeh Forouzanfar, Sebastian Eilebrecht, Benoît Van Driessche, Amina Aït-Ammar, Roxane Verdikt, Yoshihito Kurashige, Céline Marban, Virginie Gautier, Ermanno Candolfi et al. · 2016 · Scientific Reports
  35. HIC1 loss promotes prostate cancer metastasis by triggering epithelial–mesenchymal transition
    Mingang Hao, Yue Li, Jinglong Wang, Jun Qin, Yingying Wang, Yufeng Ding, Min Jiang, Xueqing Sun, Lidong Zu, Kun Sang Chang et al. · 2017 · The Journal of Pathology
  36. High Resolution Loss of Heterozygosity Mapping of 17p13 in Thyroid Cancer: Hurthle Cell Carcinomas Exhibit a Small 411-Kilobase Common Region of Allelic Imbalance, Probably Containing a Novel Tumor Suppressor Gene
    Kathryn J. Farrand, Brett Delahunt, Xiao-li Wang, Bryan McIver, IAN D. HAY, John R. Goellner, Norman L. Eberhardt, Stefan K. G. Grebe · 2002 · The Journal of Clinical Endocrinology & Metabolism
  37. Molecular analysis of the lissencephaly gene 1 (LIS‐1) in medulloblastomas
    A. Koch, J. Tonnt, J. A. KRAUS, N. Sörensen, Steffen Albrecht, O. D. Wiestler, Torsten Pietsch · 1996 · Neuropathology and Applied Neurobiology
  38. Molecular Neuropathology of Astrocytic Brain Tumors
    Torsten Pietsch, Otmar D. Wiestler · 1997 · Journal of Neuro-Oncology
  39. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma
    Heike Stöcklein, Jana Šmardová, J Mačák, Tiemo Katzenberger, Sylvia Höller, Swen Weßendorf, Grit Hutter, Martin H. Dreyling, Eugenia Haralambieva, Uwe Mäder et al. · 2007 · Oncogene
  40. Adrenocortical carcinoma
    Christine Gicquel, Éric Baudin, Yves Le Bouc, Martin Jean Schlumberger · 1997 · Annals of Oncology
  41. HIC1 links retinoic acid signalling to group 3 innate lymphoid cell-dependent regulation of intestinal immunity and homeostasis
    Kyle Burrows, Frann Antignano, Alistair Chenery, Michael Bramhall, Vladimír Kořínek, T. Michael Underhill, Colby Zaph · 2018 · PLoS Pathogens
  42. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
    Ippei Kawano, Michaela Adamcová · 2022 · Frontiers in Pharmacology
  43. Novel Systemic Therapies for Small Cell Lung Cancer
    Charles M. Rudin, Christine L. Hann, Craig D. Peacock, D. Neil Watkins · 2008 · Journal of the National Comprehensive Cancer Network
  44. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma
    Juergen Brieger, Warut Pongsapich, Sylvia A. Mann, Jana Hedrich, Kai Fruth, Benjamin Pogozelski, Wolf Jürgen Mann · 2010 · Oral Oncology
  45. The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function
    Zhen Xing, Xin Hua Tang, Yuan Gao, Liang Da, Hai Song, Suiquan Wang, Pierre Tiollais, Tsaiping Li, Mujun Zhao · 2011 · Biochemical and Biophysical Research Communications
  46. Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia
    Jaime Cofré, João R.L. Menezes, Luciana Pizzatti, Eliana S. F. W. Abdelhay · 2012 · Cancer Cell International
  47. OVCA1: tumor suppressor gene
    Chun‐Ming Chen, Richard R. Behringer · 2004 · Current Opinion in Genetics & Development
  48. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines
    Qiwei Yang, Yufeng Tian, Kelly R. Ostler, Alexandre Chlenski, Lisa J. Guerrero, Helen R. Salwen, Lucy A. Godley, Susan Lerner Cohn · 2010 · BMC Cancer
  49. Identification of Novel Subregions of LOH in Gastric Cancer and Analysis of the HIC1 and TOB1 Tumor Suppressor Genes in These Subregions
    Jingcui Yu, Peng Liu, Xiaobo Cui, Yu Sui, Guohua Ji, Rongwei Guan, Donglin Sun, Wei Ji, Fangli Liu, An Liu et al. · 2011 · Molecules and Cells
  50. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas
    J. Papp, B. Csókay, P Bõsze, Z. Zalay, József Tóth, B. A. J. Ponder, Edith Oláh · 1996 · British Journal of Cancer
  51. Epigenetics of Neurological Cancers
    Shaun D. Fouse, J Costello · 2009 · Future Oncology
  52. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma
    Pei Li, Xiang Liu, Ziming Dong, Zhi‐Qiang Ling · 2015 · Oncotarget
  53. Gestational oral low-dose estradiol-17β induces altered DNA methylation of CDKN2D and PSAT1 in embryos and adult offspring
    Vera Anna van der Weijden, Veronika L. Flöter, Susanne Ernestine Ulbrich · 2018 · Scientific Reports
  54. Loss of a single Hic1 allele accelerates polyp formation in ApcΔ716 mice
    Helai P. Mohammad, W Zhang, Helen Prevas, Benjamin R. Leadem, Meiying Zhang, James Gordon Herman, Craig M. Hooker, D. Neil Watkins, Baktiar O. Karim, David L. Huso et al. · 2011 · Oncogene
  55. Tumour suppressor genes in sporadic epithelial ovarian cancer
    Ying Liu, TS Ganesan · 2002 · Reproduction
  56. Abnormal Methylation of Several Tumor Suppressor Genes in Sporadic Breast Cancer
    Valeria V Zemlyakova, A. I. Zhevlova, V. V. Strelnikov, Liudmila N. Lyubchenko, M. A. Shabanov, Yа. V. Vishnevskaya, В А Третьякова, Dmitry V. Zaletaev, Marina V. Nemtsova · 2003 · Molecular Biology
  57. Genetic markers for early detection of lung cancer and outcome measures for response to chemoprevention.
    Jonathan S. Wiest, Wilbur A. Franklin, Harry A. Drabkin, Robert M. Gemmill, David Sidransky, Marshall W. Anderson · 1997 · PubMed
  58. HIC1 interacts with and modulates the activity of STAT3
    Ying-Mei Lin, Chia-Mei Wang, Jen‐Chong Jeng, Dominique Leprince, Hsiu‐Ming Shih · 2013 · Cell Cycle
  59. Just Say No to ATOH: How HIC1 Methylation Might Predispose Medulloblastoma to Lineage Addiction
    Kimberly J. Briggs, Charles G. Eberhart, D. Neil Watkins · 2008 · Cancer Research
  60. Epigenetics of Colorectal Cancer
    Wenji Yan, Mingzhou Guo · 2014 · Methods in molecular biology
  61. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers
    France Dion, Anne‐Marie Mes‐Masson, Robert J. Seymour, Diane Michele Provencher, Patricia N. Tonin · 2000 · Oncogene
  62. High-Risk Myelodysplastic Syndromes and Hypermethylation of the p15Ink4BGene
    Toshiki Uchida, Tomohiro Kinoshita, Tomomitsu Hotta, Takashi Murate · 1998 · Leukemia & lymphoma/Leukemia and lymphoma
  63. Alterations in Promoter Methylation Status of Tumor Suppressor HIC1 , SFRP2 , and DAPK1 Genes in Prostate Carcinomas
    Devran Kilinc, Öztürk Özdemir, Semra Özdemir, Esat Korğalı, Binnur Köksal, Atilla Uslu, Yener Gültekin · 2011 · DNA and Cell Biology
  64. Monoclonal Antibodies to Kaiso: A Novel Transcription Factor and p120 ctn -Binding Protein
    Juliet M. Daniel, Reneé C. Ireton, Albert B. Reynolds · 2001 · Hybridoma
  65. Gene expression microarray analysis and genome databases facilitate the characterization of a chromosome 22 derived homogenously staining region
    Suzanna L. Arcand, Anne‐Marie Mes‐Masson, Diane Michele Provencher, Thomas J. Hudson, Patricia N. Tonin · 2004 · Molecular Carcinogenesis
  66. Characterisation of X;17(q12;p13) translocation breakpoints in a female patient with hypomelanosis of Ito and choroid plexus papilloma.
    Vladimír Zajac, Tomas Kirchhoff, Elaine R. Levy, Sharon W. Horsley, A Miller, Elisabeth Steichen‐Gersdorf, Anthony P. Monaco · 1997 · PubMed
  67. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene
    Daniel S. Liscia, R. Morizio, Tiziana Venesio, C Palenzona, Michela Donadio, Robert Callahan · 1999 · British Journal of Cancer
  68. Increased expression of the LAZ3 (BCL6) proto-oncogene accompanies murine skeletal myogenesis
    Olivier Albagli, Philippe Dhordain, Danièle Lantoine, Sabine Quief, Jean‐Pierre Kerckaert, Frédéric Aurade, Didier Montarras, Christian Pinset · 1998 · Differentiation
  69. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement
    Lise Lotte Hansen, JØRN ERIK ANDERSEN, Jens Overgaard, Torben Arvid Kruse · 1998 · Apmis
  70. The Human ROX Gene: Genomic Structure and Mutation Analysis in Human Breast Tumors
    Cristiana Lo Nigro, Tiziana Venesio, Alexandre Reymond, Germana Meroni, Paola Alberici, Silvia Cainarca, Fiorenza Enrico, Maria Stack, David H. Ledbetter, Daniel S. Liscia et al. · 1998 · Genomics
  71. 14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome region.
    Samuel S. Chong, Akira Tanigami, Anna V. Roschke, David H. Ledbetter · 1996 · Genome Research
  72. Identification of p21 (CIP1/WAF1) as a direct target gene of HIC1 (Hypermethylated In Cancer 1)
    Vanessa Dehennaut, Ingrid Loison, Gaylor Boulay, Capucine Van Rechem, Dominique Leprince · 2012 · Biochemical and Biophysical Research Communications
  73. Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway
    Xiumin Wang, Yingying Wang, Gang Xiao, Jinglong Wang, Lidong Zu, Mingang Hao, Xueqing Sun, Yujie Fu, Guohong Hu, Jianhua Wang · 2016 · Oncotarget
  74. Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells
    Juergen Brieger · 2011 · International Journal of Molecular Medicine
  75. Stem cells, cancer, and epigenetics
    Baylin · 2009 · StemBook
  76. Generation of two modified mouse alleles of the Hic1 tumor suppressor gene
    Vendula Pospíchalová, Jolana Turečková, Bohumil Fafílek, Martina Vojtěchová, Michaela Krausová, Jan Lukáš, Eva Šloncová, Sylvia Takáčová, Vladimír Divoký, Dominique Leprince et al. · 2011 · genesis
  77. Two variants of the human hepatocellular carcinoma‐associated HCAP1 gene and their effect on the growth of the human liver cancer cell line Hep3B
    Dafang Wan, Mei He, Junru Wang, Xiaokun Qiu, Wei Jie Zhou, Zewei Luo, Jianguo Chen, Jianren Gu · 2003 · Genes Chromosomes and Cancer
  78. Loss of heterozygosity of a locus in the chromosomal region 17p13.3 is associated with increased cell proliferation in astrocytic tumors
    Chitra Sarkar, Parthaprasad Chattopadhyay, Angela Mercy Ralte, Ashok Kumar Mahapatra, Subrata Sinha · 2003 · Cancer Genetics and Cytogenetics
  79. Low Frequency of Loss and Heterozygosity At the Nevoid Basal Cell Carcinoma Locus and Other Selected Loci in Appendageal Tumors
    Minoru Takata, Anthony Quinn, Ken Hashimoto, Jonathan L. Rees · 1996 · Journal of Investigative Dermatology
  80. HIC1 modulates uveal melanoma progression by activating lncRNA-numb
    Guangcun Cheng, Jie He, Leilei Zhang, Shengfang Ge, He Zhang, Xianqun Fan · 2016 · Tumor Biology
  81. Hepatic Tumors in Childhood
    Milton J. Finegold, Dolores H Lopez-Terrada · 2014 · Springer eBooks
  82. Molecular Cloning and Chromosomal Mapping of the Human Homologue of MYB Binding Protein (P160) 1A (MYBBP1A) to 17p13.3
    Rebecca A. Keough, Erica Woollatt, Joanna Crawford, Grant R. Sutherland, Sarah J. Plummer, Graham Casey, Thomas J. Gonda · 1999 · Genomics
  83. Regulation of the Cyclin-dependent Kinase Inhibitor 1A Gene (CDKN1A) by the Repressor BOZF1 through Inhibition of p53 Acetylation and Transcription Factor Sp1 Binding
    Min-Kyeong Kim, Bu‐Nam Jeon, Dong‐In Koh, Kyung‐Sup Kim, So-Yoon Park, Chae‐Ok Yun, Man‐Wook Hur · 2013 · Journal of Biological Chemistry
  84. Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective
    Meseret Derbew Molla, Gashaw Dessie, Yonas Akalu, Birhanu Ayelign · 2020 · International Journal of Hepatology
  85. Physical and Transcriptional Mapping of the 17p13.3 Region That Is Frequently Deleted in Human Cancer
    Céline Hoff, Peter Seranski, Jan Mollenhauer, Bernhard Korn, Tanja Detzel, Richard Reinhardt, Juliane Ramser, Annemarie Poustka · 2000 · Genomics
  86. Epigenetic regulation of cell life and death decisions and deregulation in cancer
    Nabil Hajji, Bertrand Joseph · 2010 · Essays in Biochemistry
  87. DNA cytosine methylation profile in various cancer-related genes is altered in cultured rat hepatocyte cell lines as compared with primary hepatocytes
    Kiyoshi Asada, Rumiko Asada, Hitoshi Yoshiji, Hiroshi Fukui, Robert A. Floyd, Yashige Kotake · 2006 · Oncology Reports
  88. Identification of a second G–C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1
    Sébastien Pinte, Cateline Guérardel, Sophie Deltour, Andrew K. Godwin, Dominique Leprince · 2004 · Oncogene
  89. Prognostic Significance of p53 Expression, Chromosome 17 Copy Number, and DNA Ploidy in Non-Metastasized Colorectal Carcinomas (Stages IB and II)
    Gustavo Bruno Baretton, M. Vogt, C. Müller, Joachim Diebold, Karin Schneiderbanger, M. Schmidt, U. Löhrs · 1996 · Scandinavian Journal of Gastroenterology
  90. miR-212 and miR-132 are dispensable for mouse mammary gland development
    Hiroyuki Kayo, Kotaro Kiga, Y. Fukuda, Sebastian Hedlund, Kazuyoshi Murakami, Inti Alberto De La Rosa-Velázquez, Tokuhiro Kimura, Kouji Shimoda, M. Tanabe, Taro Fukao · 2014 · Nature Genetics
  91. Myoneurin regulates BMP signaling by competing with Ppm1a for Smad binding
    Shuyan Yang, Guozhu Ning, Yiming Hou, Yu Cao, Jin Xu, Jianxin Wu, Ting Zhang, Qiang Wang · 2022 · iScience
  92. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP
    Nicolas Stankovic‐Valentin, Alexis Verger, Sophie Deltour, Kate G R Quinlan, Merlin Crossley, Dominique Leprince · 2006 · FEBS Journal
  93. Inactivation of the hypermethylated in cancer 1 tumour suppressor – not just a question of promoter hypermethylation?
    Mathias Jenal, Christian Britschgi, MF Fey, Mario P. Tschan · 2010 · Swiss Medical Weekly
  94. Allelic imbalance at chromosome 17p13.3 (YNZ22) in breast cancer is independent of p53 mutation or p53 overexpression and is associated with poor prognosis at medium-term follow-up
    AM Thompson, D.N. Crichton, R. A. Elton, MF Clay, Utheshtra Chetty, C. Michael Steel · 1998 · British Journal of Cancer
  95. HIC 2, a new transcription activator of SIRT 1
    Ji‐Yang Song, Seung‐Hyun Lee, M.K. Kim, Bu‐Nam Jeon, Su‐Yeon Cho, Sun‐Ho Lee, Kyung‐Sup Kim, Man‐Wook Hur · 2019 · FEBS Letters
  96. RETRACTED ARTICLE: KDM6B Histone Demethylase is an Epigenetic Regulator of Estrogen Receptor β Expression in Human Pleural Mesothelioma
    Arcangela Gabriella Manente, Giulia Pinton, Sara Zonca, Daniela Tavian, Tanwir Habib, Puthen Veettil Jithesh, Dean Anthony Fennell, Stefan V. Nilsson, Laura Moro · 2016 · Epigenomics · Retracted
  97. Development and function of smooth muscle cells is modulated by Hic1 in mouse testis
    Aya Uchida, Sadman Sakib, Elodie Labit, Sepideh Abbasi, R. Wilder Scott, T. Michael Underhill, Jeff A. Biernaskie, Ina Dobrinski · 2020 · Development
  98. The carboxy-terminal end of the candidate tumor suppressor gene HIC-1 is phylogenetically conserved
    Sophie Deltour, Cateline Guérardel, D. Stéhelin, Dominique Leprince · 1998 · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
  99. Cloning, Structure, and Expression of the Mouse Ovca1 Gene
    Chun‐Ming Chen, Richard R. Behringer · 2001 · Biochemical and Biophysical Research Communications
  100. Three New Regions on Chromosome 17p13.3 Distal to p53 with Possible Tumor Suppressor Gene Involvement in Lung Cancer
    Eiju Tsuchiya, Akira Tanigami, Yuichi Ishikawa, 一典 西田, Moriaki Hayashi, Yoshio Tokuchi, Takehisa Hashimoto, Sakae Okumura, Shigehiro Tsuchiya, Ken Nakagawa · 2000 · Japanese Journal of Cancer Research